Rebecca Moore

Rebecca Moore is currently a Senior Scientist at SpyBiotech, focusing on HIV-1 vaccine design. Previously, Rebecca worked as a Postdoctoral Researcher and Laboratory manager at the University of Oxford, where Rebecca also collaborated on SARS-CoV-2 vaccine development. Prior to that, Rebecca was a Visiting NIH Postdoctoral Research Fellow at the HIV Drug Resistance Program. Rebecca's research background includes analyzing interactions between HIV-1 Vif and APOBEC3 proteins, as well as developing gene therapy vectors using virological and molecular biology techniques. Rebecca holds a PhD in Virology and Gene Therapy from Imperial College London and a BS in Virology from the University of Warwick.